Absence of fetal nasal bone and aneuploidies at first‐trimester nuchal translucency screening in unselected pregnancies
- 14 May 2003
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 23 (6) , 496-500
- https://doi.org/10.1002/pd.628
Abstract
Objectives: The absence of nasal bone (NB) has been noted in trisomy 21 fetuses at first‐trimester ultrasound, in high‐risk pregnancies. In this study, the nasal bone was evaluated in relation to fetal karyotype, in unselected pregnancies.Methods: From September 2001 to September 2002, the fetal facial profile was examined at the 11 to 14 weeks' scan for screening by nuchal translucency (NT). Risks for trisomy 21 were calculated using the Fetal Medicine Foundation's software, and the presence or absence of NB was noted. Prenatal karyotype and pregnancy outcomes were recorded.Results: NT screening was performed in 5532 fetuses from 5425 pregnancies (85 twins, 8 triplets, 2 quadruplets). The visualization of fetal profile was obtained in 5525 fetuses (99.8%), and in 5491 fetuses (99.4%) the NB was present and in 34 cases (0.6%) it was absent. Fetal karyotype and pregnancy outcome were available in 3503 pregnancies, and 40 chromosomal abnormalities were diagnosed (27 trisomies 21, 5 trisomies 18, 2 trisomies 13, 3 Turner syndromes, 1 partial trisomy 9 and 2 others). The NB was absent in 19 (70%) trisomies 21, 4 trisomies 18 (80%), 2 Turner syndromes (66%), in the partial trisomy 9, in 7 normal karyotype fetuses (0.2%), and in a case with spontaneous first‐trimester abortion before prenatal diagnosis. A significant difference was found between NT thickness, expressed as a multiple of the median, in trisomy 21 fetuses with present and absent nasal bone.Conclusions: The absence of NB at 11 to 14 weeks is more frequent in fetuses with trisomy 21 and other aneuploidies than in normal karyotype fetuses. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 17 references indexed in Scilit:
- Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestationThe Journal of Maternal-Fetal & Neonatal Medicine, 2002
- Absence of nasal bone and detection of trisomy 21The Lancet, 2002
- Fetal nuchal translucency screening in 12 495 pregnancies in SardiniaUltrasound in Obstetrics & Gynecology, 2001
- Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational studyThe Lancet, 2001
- Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and olderObstetrics & Gynecology, 2001
- Assessment of Risk for Chromosomal Abnormalities at 10–14 Weeks of Gestation by Nuchal Translucency and Maternal Age in 5,210 Fetuses at a Single CentreFetal Diagnosis and Therapy, 2000
- Skeletal abnormalities in fetuses with Down's syndrome: a radiographic post-mortem studyPediatric Radiology, 1999
- Fetal nuchal translicency test for Down's syndromeThe Lancet, 1997
- Pattern of malformations in the axial skeleton in human trisomy 21 fetusesAmerican Journal of Medical Genetics, 1997
- First‐trimester ultrasound screening for chromosomal defectsUltrasound in Obstetrics & Gynecology, 1996